Healthcare provider profile · identity verified

Nicholas John Brahm, DO

Family Practice · HARTFORD, WI · NPI 1245414861

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	139
Amlodipine Besylate	Amlodipine Besylate	276	78
Lisinopril	Lisinopril	235	69
Omeprazole	Omeprazole	234	64
Levothyroxine Sodium	Levothyroxine Sodium	225	62
Losartan Potassium	Losartan Potassium	197	56
Metformin Hcl	Metformin Hcl	190	52
Furosemide	Furosemide	187	43
Albuterol Sulfate Hfa	Albuterol Sulfate	184	59
Metoprolol Succinate	Metoprolol Succinate	178	50
Gabapentin	Gabapentin	159	43
Famotidine	Famotidine	132	30
Potassium Chloride	Potassium Chloride	131	37
Metoprolol Tartrate	Metoprolol Tartrate	119	33
Pantoprazole Sodium	Pantoprazole Sodium	118	40
Trazodone Hcl	Trazodone Hcl	114	34
Eliquis	Apixaban	109	27
Tamsulosin Hcl	Tamsulosin Hcl	109	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	25
Rosuvastatin Calcium	Rosuvastatin Calcium	96	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	28
Metformin Hcl Er	Metformin Hcl	93	28
Simvastatin	Simvastatin	90	23
Hydrochlorothiazide	Hydrochlorothiazide	89	32
Carvedilol	Carvedilol	84	23
Clopidogrel	Clopidogrel Bisulfate	81	21
Fluticasone Propionate	Fluticasone Propionate	80	34
Ozempic	Semaglutide	68	24
Alendronate Sodium	Alendronate Sodium	66	19
Allopurinol	Allopurinol	63	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	21
Duloxetine Hcl	Duloxetine Hcl	61	19
Montelukast Sodium	Montelukast Sodium	60	21
Mirtazapine	Mirtazapine	59	16
Glipizide	Glipizide	58	15
Spironolactone	Spironolactone	57	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	18
Tramadol Hcl	Tramadol Hcl	55	20
Sertraline Hcl	Sertraline Hcl	53	12
Finasteride	Finasteride	51	18
Fluoxetine Hcl	Fluoxetine Hcl	51	14
Mounjaro	Tirzepatide	51	14
Jardiance	Empagliflozin	50	15
Atenolol	Atenolol	49	12
Escitalopram Oxalate	Escitalopram Oxalate	49	16
Januvia	Sitagliptin Phosphate	49	14
Pravastatin Sodium	Pravastatin Sodium	48	13
Triamcinolone Acetonide	Triamcinolone Acetonide	48	23
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	44	22
Lorazepam	Lorazepam	44	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	12
Quetiapine Fumarate	Quetiapine Fumarate	40	11
Ropinirole Hcl	Ropinirole Hcl	39	12
Spiriva Handihaler	Tiotropium Bromide	38	suppressed
Trulicity	Dulaglutide	38	11
Warfarin Sodium	Warfarin Sodium	38	12
Ondansetron Hcl	Ondansetron Hcl	37	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Topiramate	Topiramate	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Azithromycin	Azithromycin	33	18
Bupropion Xl	Bupropion Hcl	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	11
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	11
Enalapril Maleate	Enalapril Maleate	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	26	11
Cephalexin	Cephalexin	25	14
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Diazepam	Diazepam	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Prednisone	Prednisone	23	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	21	suppressed
Nystatin	Nystatin	20	12
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Fluconazole	Fluconazole	19	12
Lamotrigine	Lamotrigine	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Estradiol	Estradiol	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Atrovent Hfa	Ipratropium Bromide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Naproxen	Naproxen	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Linzess	Linaclotide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Cefdinir	Cefdinir	13	13
Clotrimazole	Clotrimazole	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Acyclovir	Acyclovir	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Colchicine	Colchicine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error